The promising role of miR-296 in human cancer

被引:23
|
作者
Zhu, Lingling [1 ]
Deng, Hanyu [1 ]
Hu, Jia [1 ]
Huang, Shanshan [2 ]
Xiong, Jianping [2 ]
Deng, Jun [2 ]
机构
[1] Sichuan Univ, West China Hosp, Lung Canc Ctr, Chengdu, Sichuan, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
MiR-296; Cancer; Target genes; CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; MICRORNA EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; TUMOR INVASION; GASTRIC-CANCER; PROLIFERATION;
D O I
10.1016/j.prp.2018.09.026
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
MicroRNAs (MiRNAs) are small non-protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial-mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.
引用
收藏
页码:1915 / 1922
页数:8
相关论文
共 50 条
  • [1] miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo
    Savi, Federica
    Forno, Irene
    Faversani, Alice
    Luciani, Andrea
    Caldiera, Sarah
    Gatti, Stefano
    Foa, Paolo
    Ricca, Dario
    Bulfamante, Gaetano
    Vaira, Valentina
    Bosari, Silvano
    CLINICAL SCIENCE, 2014, 127 (3-4) : 233 - 242
  • [2] A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA
    Cazanave, Sophie C.
    Mott, Justin L.
    Elmi, Nafi Sa A.
    Bronk, Steven F.
    Masuoka, Howard C.
    Charlton, Michael R.
    Gores, Gregory J.
    JOURNAL OF LIPID RESEARCH, 2011, 52 (08) : 1517 - 1525
  • [4] miR-296 and Modulation of Tumor Growth in Systemic Malignancies
    Kapoor, Shailendra
    ANNALS OF THORACIC SURGERY, 2013, 96 (01): : 378 - 379
  • [5] MiR-296 Promotes Osteoblast Differentiation by Upregulating Cbfal
    Yu, Shengjun
    Luan, Jingjie
    Liu, Yunyan
    Su, Yue
    Li, Xiao
    PHARMACOLOGY, 2020, 105 (3-4) : 190 - 201
  • [6] Elevated Expression of miR-296 in Human Placentas and Serum Samples From Pregnancies With Preeclampsia
    Zhu, Dandan
    Guo, Ting
    Xu, Jie
    Yuan, Donglan
    Lin, Mei
    Yang, Minyan
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2023, 80
  • [7] ALTERED MIR-296 REGULATES PUMA EXPRESSION AND HEPATOCYTE LIPOAPOPTOSIS
    Gores, Gregory J.
    Cazanave, Sophie
    Mott, Justin L.
    Elmi, Nafisa
    Bronk, Steven F.
    Charlton, Michael R.
    HEPATOLOGY, 2010, 52 (04) : 422A - 422A
  • [8] MiR-296 promotes colorectal cancer cells growth through regulating NF-κB
    Zhai, Huiyuan
    Sui, Minghua
    Jiang, Lixin
    Hu, Jinchen
    Jiang, Xiaorui
    Yuan, Yuan
    Li, Mingchuan
    Yu, Zhenyu
    Hu, Sanyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4391 - 4396
  • [9] The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma
    Hong, Liu
    Han, Yu
    Zhang, Hongwei
    Li, Mengbin
    Gong, Taiqian
    Sun, Li
    Wu, Kaichun
    Zhao, Qingchuan
    Fan, Daiming
    ANNALS OF SURGERY, 2010, 251 (06) : 1056 - 1063
  • [10] THERAPEUTIC POTENTIAL OF LET-7, MIR-125, MIR-205, AND MIR-296 IN BREAST CANCER: AN UPDATE
    Barh, Debmalya
    Vedamurthy, A. B.
    IIOAB JOURNAL, 2013, 4 (01) : 27 - 28